Patent US5284933A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5284933A Expired / Lapsed US ⏱️ 0.0 years remaining

Affinity peptides

Assignee: Roche Diagnostics Corp
•
Filing: 1988-02-22
•
Granted: 1994-02-08
•
Expires: 2008-02-22
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Fusion proteins and a process for their purification by means of metal chelate affinity chromatography on NTA resins are provided by this invention.

Inventors

  • 👤 Heinz Dobeli
  • 👤 Bernhard Eggimann
  • 👤 Reiner Gentz
  • 👤 Erich Hochuli
  • 👤 Dietrich Stuber

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-25 21:50
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/435; C07K14/52; C07K14/555; C07K14/57; C12; C12N; C12N15/00; C12N15/09; C12N15/11; C12N15/62; C12N15/63; C12N15/70; A; A61; A61K; A61K38/00; C07K2319/00; C07K2319/20; C07K2319/21; C07K2319/50; C07K2319/70; C07K2319/74; C07K2319/75

Claims Analysis

Total Claims: 12
Claim 1
Independent Claim 76 words
A fusion protein comprising a biologically active polypeptide or protein linked by its amino- and/or carboxyl-terminus to one or two affinity peptides, which affinity peptides have the formula R.sup.1 --(His).sub.2-6 --R.sup.2, wherein R 1 is hydrogen or a peptide chain formed from about 1 to about 30 amino acids; and R 2 is Q, Q-Ile-Glu-Gly-Arg- or Q-Asp-Asp-Asp-Asp-Lys, where Q is a peptide bond or a peptide chain formed from about 1 to about 30 amino acids.
Claim 2
Dependent Claim 76 words
A fusion protein comprising a biologically active polypeptide or protein linked by its amino- and/or carboxyl-terminus to one or two affinity peptides, which affinity peptides have the formula R.sup.1 --(His).sub.2-6 --R.sup.2, wherein R 1 is hydrogen or a peptide chain formed from about 1 to about 30 amino acids; and R 2 is Q, Q-Ile-Glu-Gly-Arg- or Q-Asp-Asp-Asp-Asp-Lys, where Q is a peptide bond or a peptide chain formed from about 1 to about 30 amino acids.
Claim 3
Dependent Claim 23 words
The fusion protein of claim 1 in which the affinity peptides have an amino acid sequence selected from the group consisting of ##STR3##
Claim 4
Dependent Claim 31 words
The fusion protein of claim 1 in which at least one of the links between the biologically active polypeptide or protein and the affinity peptides can be cleaved by a protease.
Claim 5
Dependent Claim 12 words
The fusion protein of claim 3 in which the protease is enterokinase.
Claim 6
Dependent Claim 16 words
The fusion protein of claim 3 in which the protease is coagulation factor X a .
Claim 7
Dependent Claim 15 words
The fusion protein of claim 1 in which the affinity peptides complex immobilized nickel ions.
Claim 8
Dependent Claim 37 words
The fusion protein of claim 1 in which the biologically active polypeptide or protein has an amino acid sequence corresponding to the sequence of human immune interferon, a subsequence of human immune interferon, or mouse dihydrofolate reductase.
Claim 9
Dependent Claim 10 words
The fusion protein of claim 1 which is essentially pure.
Claim 10
Dependent Claim 53 words
An affinity peptide of formula R.sup.1 --(His).sub.2-6 --R.sup.2, wherein R 1 is hydrogen or a peptide chain formed from about 1 to about 30 amino acids; and R 2 is Q, Q-Ile-Glu-Gly-Arg- or Q-Asp-Asp-Asp-Asp-Lys-, where Q is a peptide bond or a peptide chain formed from about 1 to about 30 amino acids.
Claim 11
Dependent Claim 53 words
An affinity peptide of formula R.sup.1 --(His).sub.2-6 --R.sup.2, wherein R 1 is hydrogen or a peptide chain formed from about 1 to about 30 amino acids; and R 2 is Q, Q-Ile-Glu-Gly-Arg- or Q-Asp-Asp-Asp-Asp-Lys-, where Q is a peptide bond or a peptide chain formed from about 1 to about 30 amino acids.
Claim 12
Dependent Claim 18 words
The affinity peptide of claim 9 having an amino acid sequence selected from the group consisting of ##STR4##

References Cited (Backward Citations)

EP0161937A2 Cited
US4569794A Cited
US4877830A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1997-02-07 1997-08-09 1998-02-08 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2001-02-07 2001-08-09 2002-02-08 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2005-02-07 2005-08-09 2006-02-08 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag